ARCHIVES

NCI Advisors Approve New Grant Programs Worth $100 Million

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

October 24, 2014

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

Gavel Changes Hands At NCAB, Korn advises New Members On Role

February 8, 1991